Cohance Lifesciences Ltd Financials

Cohance Lifesciences Ltd Share Price
Detail Overview
Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹449.85
-4.00(-0.88%)
As on 23 Oct 2026 at 15:58
As of 23 Oct 2026 at 15:58, Cohance Lifesciences Ltd is trading at ₹449.85. The 52-week range stands at ₹266.70–₹903.40, with a market cap of ₹17.17 thousand crore. At a P/E of 89.73 and a dividend yield of 0.00%, it is a mid-cap stock in the Pharmaceuticals sector.

Cohance Lifesciences Ltd Financial Statements

01,0002,0003,000₹1,051FY24+138.21%₹2,504FY25-18.92%₹2,031FY26

*All values are in INR Crore

Frequently asked questions

The Cohance Lifesciences Ltd revenue for the latest reported period is ₹2,031 crore, compared with ₹2,504 crore in the previous period.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now